These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 8734805

  • 1. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G, Goldman B, Ries L, Chaki R, Cuckle H.
    Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
    [Abstract] [Full Text] [Related]

  • 2. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ, Watt HC.
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [Abstract] [Full Text] [Related]

  • 3. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG.
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [Abstract] [Full Text] [Related]

  • 4. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
    Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM.
    Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
    [Abstract] [Full Text] [Related]

  • 5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA.
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [Abstract] [Full Text] [Related]

  • 6. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS, Haverkamp AD, Stark CF, Haverkamp C, Barth CK.
    J Matern Fetal Med; 1996 Apr; 5(2):70-3. PubMed ID: 8796771
    [Abstract] [Full Text] [Related]

  • 7. Down's syndrome screening marker levels following assisted reproduction.
    Barkai G, Goldman B, Ries L, Chaki R, Dor J, Cuckle H.
    Prenat Diagn; 1996 Dec; 16(12):1111-4. PubMed ID: 8994246
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ, Hsieh TT, Soong YK, Spencer K.
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [Abstract] [Full Text] [Related]

  • 9. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S, Wang Y, Ye G.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [Abstract] [Full Text] [Related]

  • 10. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
    Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL.
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
    [Abstract] [Full Text] [Related]

  • 11. [Serum screening of pregnant women reveals Down syndrome. Analysis of biochemical markers for earlier detection].
    Christiansen M, Larsen SO, Nørgaard-Pedersen B.
    Lakartidningen; 1997 Dec 17; 94(51-52):4898-902. PubMed ID: 9454010
    [Abstract] [Full Text] [Related]

  • 12. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].
    Qi QW, Jiang YL, Liu JT, Bian XM, Li Y, Lü SM, Zhu BS, Wang H, Xu ZF, Pan XY, Cai Y.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct 17; 43(10):737-41. PubMed ID: 19087538
    [Abstract] [Full Text] [Related]

  • 13. Maternal serum markers for Down's syndrome pregnancies.
    Chew S, Anandakumar C, Ratnam SS.
    Singapore Med J; 1995 Aug 17; 36(4):417-23. PubMed ID: 8919160
    [Abstract] [Full Text] [Related]

  • 14. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
    Palomaki GE, Knight GJ, Haddow JE, Canick JA, Wald NJ, Kennard A.
    Obstet Gynecol; 1993 May 17; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315
    [Abstract] [Full Text] [Related]

  • 15. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
    Suzumori K, Tanemura M, Murakami I, Okada S, Natori M, Tanaka M, Takagi T, Sato A.
    Prenat Diagn; 1997 Sep 17; 17(9):861-6. PubMed ID: 9316131
    [Abstract] [Full Text] [Related]

  • 16. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
    Extermann P, Bischof P, Marguerat P, Mermillod B.
    Hum Reprod; 1998 Jan 17; 13(1):220-3. PubMed ID: 9512261
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
    MacDonald ML, Wagner RM, Slotnick RN.
    Obstet Gynecol; 1991 Jan 17; 77(1):63-8. PubMed ID: 1701526
    [Abstract] [Full Text] [Related]

  • 18. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S, Chandeying V.
    J Med Assoc Thai; 2007 Oct 17; 90(10):1970-6. PubMed ID: 18041410
    [Abstract] [Full Text] [Related]

  • 19. [Screening by maternal serum markers for Down's syndrome].
    Liu JT, Hao N, Sun NH, Wang FY, Xu YH, Gai MY, Bian XM, Yang JQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr 17; 25(2):156-9. PubMed ID: 12905710
    [Abstract] [Full Text] [Related]

  • 20. SURUSS in perspective.
    Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A.
    Semin Perinatol; 2005 Aug 17; 29(4):225-35. PubMed ID: 16104673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.